ECLLA News
Welcome to ECLLA News, where we share updates on our work, key activities, and developments across the European CLL community. Stay informed about our initiatives, events, and efforts to strengthen collaboration and improve CLL care across Europe.
📰 ECLLA Newsletter – October 2026 Edition Now Available
The European CLL Association (ECLLA) is pleased to announce the release of the October 2026 edition of the ECLLA Newsletter. In this edition, we share some exciting milestones as ECLLA continues to grow and strengthen its European network. You'll find highlights from...
📢 ECLLA Publishes European Policy Brief 2026 and Launches It at the European Parliament
The European CLL Association (ECLLA) has published its European Policy Brief 2026, setting out key priorities and recommendations to help address inequalities in chronic lymphocytic leukaemia (CLL) care across Europe. The Brief was formally launched on 30 September...
Invitation: Policy Dialogue at the European Parliament & Launch of ECLLA’s European Policy Brief | 30 September 2026 – REGISTRATION OPEN
Dear members and friends, We are pleased to invite you to join us for Blood Cancers and CLL on the European Agenda: From Recognition to Action, a high-level multi-stakeholder policy dialogue hosted by MEP Regina Doherty and organised by the European CLL Association...
🎓 ECLLA CLUB: Join Our Second Educational Session “Immune Health in CLL” September, 29th – REGISTRATION OPEN
Dear ECLLA Members, We are pleased to invite you to our second ECLLA Club session: Immune Health in CLL. This interactive session will feature an expert-led presentation by Dr Lydia Scarfò, Assistant Professor of Internal Medicine & Consultant Haematologist,...
📢 ECLLA Launches New European Insight Paper on Time Off Treatment in CLL
New ECLLA European Holistic Framework explores how people living with CLL can be supported before, during and after fixed-duration treatment The European CLL Association (ECLLA) is pleased to launch its new European Insight Paper, Time Off Treatment in CLL: The...
Let’s Mark Blood Cancer Awareness Month Together: Share Your September Activities
Dear ECLLA Members, We are looking forward to Blood Cancer Awareness Month this September and to highlighting ECLLA’s activities, alongside the many initiatives taking place across our member community to raise awareness of CLL and blood cancers. As we finalise...
ECLLA Welcomes New Member from Portugal
The European CLL Association (ECLLA) welcomes the Associação Portuguesa Contra a Leucemia (APCL) from Portugal as the newest member of our growing European network. APCL is a national patient organisation supporting people affected by leukaemia and other...
ECLLA Newsletter – July 2026 Edition Now Available
The European CLL Association (ECLLA) is pleased to announce the release of the July 2026 edition of the ECLLA Newsletter. In this edition, we share some exciting milestones as ECLLA continues to grow and strengthen its European network. You'll find updates on our...
ECLLA welcomes Assoc. Prof. Yervand Hakobyan as the newest member of the Medical Advisory Committee
Associate Professor Hakobyan is Head of the Department of Hematology and Transfusion Medicine at the National Institute of Health of Armenia, a Board Member of the Armenian Hematology Association, a member of the European Hematology Association (EHA) Community and...
ECLLA Welcomes Its Interim Steering Committee
The European CLL Association (ECLLA) announces the appointment of its Interim Steering Committee, marking an important milestone in the organisation's ongoing development and strategic growth. Bringing together experienced patient advocates and leaders, the Interim...
ECLLA Welcomes New Member from Greece
The European CLL Association (ECLLA) is delighted to welcome the Hellenic Group of Patients with Chronic Lymphocytic Leukaemia (Greece) as the newest member of our growing European network. The Hellenic Group supports and represents people living with CLL in Greece,...
🎉 ECLLA Club Programme 2026 Launch! Join Our First Educational Session “CLL Essentials, Diagnostics & Treatment Pathways” | July, 29th – REGISTRATION OPEN
Dear ECLLA Members, We are delighted to announce the official launch of the ECLLA Club Programme 2026 and to invite you to our first session, CLL Essentials, Diagnostics & Treatment Pathways. This interactive session combines an expert-led presentation with...
🎥 Recordings Now Available: ECLLA Multi-Stakeholder Discussion on Time Off Treatment in CLL
The European CLL Association (ECLLA) is pleased to announce that recording of the multi-stakeholder panel discussion, "Time Off Treatment in CLL – Clinical Control and Patient Priorities in Fixed-Duration Treatment," is now available to watch online. Held on 11 June...
ECLLA Co-Founder Jan Rynne Joins European Discussion on the EU Biotech Act
ECLLA is proud to share that our Co-Founder, Jan Rynne, recently joined the Cancer Patients Europe (CPE) Policy Webinar as a panellist to discuss the EU Biotech Act and its potential to improve clinical trials and access to innovative cancer treatments across Europe....
ECLLA Club in Development – First Session Coming Soon
ECLLA Membership Club in Development – First Session Coming Soon ECLLA is pleased to share that preparations are underway for the first session of the ECLLA Club, a new initiative being developed exclusively for ECLLA member organisations. The Membership Club will...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Prof Oliver Karanfilski
European CLL Association - ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board. At the ECLLA...
ECLLA Co-Founder Michael Rynne Attends the Cancer Patients Europe Annual Meeting 2026
ECLLA Co-founder Michael Rynne attended the Cancer Patients Europe (CPE) Annual Meeting 2026, held in Brussels from 24–26 June under the theme "Protecting and Improving Europe's Cancer Care Model in a Changing World." The three-day meeting brought together patient...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Dr Brian Koffman
ECLLA is deeply grateful to Dr Brian Koffman, MDCM (retired) MS Ed, Co-Founder and Chief Medical Officer Emeritus, CLL Society Inc., and member of European CLL Association - ECLLA Medical Advisory Board, for bringing both professional expertise and lived experience to...
ECLLA Team Attends EHA 2026 Congress in Stockholm 11–14, 2026
The ECLLA team proudly participated in the 31st Congress of the European Hematology Association (EHA 2026), held from June 11–14, 2026, in Stockholm, Sweden. As one of the world's premier hematology events, EHA brings together leading experts, researchers, clinicians,...
📍 Live from Stockholm! Breakfast panel discussion on “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the Wider CLL Community”
Today, ECLLA is bringing together clinicians, patient advocates, care partners, nurse, and policy expert from across Europe for our multi-stakeholder panel discussion: “Time Off Treatment in CLL: Clinical Control and Patient Priorities in Fixed-Duration Treatment”...